JNJ Related Downgrades

Apr 8, 2013 07:19 AM JPMorgan Downgrades Johnson & Johnson (JNJ) to Neutral

Feb 7, 2013 06:55 AM Credit Suisse Downgrades Johnson & Johnson (JNJ) to Underperform

Nov 12, 2012 07:00 AM Jefferies Downgrades Johnson & Johnson (JNJ) to Hold, Easy Money Made

Oct 9, 2012 07:25 AM Goldman Sachs Downgrades Johnson & Johnson (JNJ) to Sell, Sees Limited Upside

Feb 2, 2012 10:15 AM First Global Downgrades Johnson & Johnson (JNJ) to Market Perform

Dec 9, 2011 01:15 PM Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals

Dec 9, 2011 07:58 AM Global Hunter Securities Downgrades Pharmacyclics (PCYC) to Neutral; Enters Global Partnership with JNJ for Btk-inhibitor PCI-32765

Nov 22, 2011 08:23 AM Leerink Swann Downgrades Pharmasset (VRUS) to Market Perform; A Befitting End to a Remarkable Biotech Story

Sep 22, 2011 01:00 PM Citi Cuts Smith & Nephew (SNN) from Buy to Sell; Considers Multiple Issues

Sep 22, 2011 07:26 AM Goldman Sachs Downgrades Johnson & Johnson (JNJ) to Neutral

Jun 24, 2011 09:59 AM UPDATE - UBS Downgraded Boston Scientific (BSX) to Neutral; Stent & ICD Markets Are About as Tough as They Get

Jun 15, 2011 02:42 PM CL King Downgrades SurModics (SRDX) as Cordis to Halt Manufacturing Cypher Stents

May 11, 2011 06:47 AM Goldman Sachs Downgrades Bristol-Myers Squibb (BMY) to Neutral, Likes Johnson & Johnson (JNJ) More

Feb 1, 2011 08:29 AM First Global Downgrades Johnson & Johnson (JNJ) to Market Perform; Delay in Resolution of McNeil Recall/OTC Issues & Increased Generic Competition

Jan 26, 2011 11:21 AM UPDATE: Noble Financial Downgrades Johnson & Johnson (JNJ) to Hold

Jan 26, 2011 09:51 AM Noble Financial Downgrades Johnson & Johnson (JNJ) to Hold

Jan 10, 2011 10:03 AM Raymond James Downgrades Johnson & Johnson (JNJ) to Market Perform

Jan 10, 2011 10:03 AM Raymond James Downgrades Johnson & Johnson (JNJ) to Market Perform

Jan 10, 2011 10:03 AM Raymond James Downgrades Johnson & Johnson (JNJ) to Market Perform

Dec 9, 2010 07:33 AM Wells Fargo Downgrades Johnson & Johnson (JNJ) to Market Perform; Moving To Sideline Until Better Visibility On Consumer Risk

Oct 7, 2010 07:40 AM Needham & Company Downgrades Crucell N.V. (CRXL) to Hold; Reach an Agreement on Acquisition With J&J

Sep 29, 2010 10:03 AM Miller Tabak Downgrades Amgen (AMGN) to Sell; Five Reasons to Drop

Aug 10, 2010 09:46 AM Morgan Stanley Downgrades J&J (JNJ) to Equal Weight

Jul 1, 2010 03:50 PM Standpoint Research Downgrades PG, JNJ, VZ to Hold; Starts CVX at Buy

Feb 11, 2010 07:32 AM Deutsche Bank Downgrades Boston Scientific (BSX) to Hold; 2010 Looks to Be Year of Rebuilding

Oct 20, 2009 06:54 AM Wells Fargo Downgrades Boston Scientific (BSX) to Market Perform; Lowers EPS Estimates

Jul 20, 2009 11:44 AM First Global Downgrades Abbott (ABT) to Market Perform

Mar 2, 2009 11:43 AM Matrix Lighthouse Rating Changes 3/2

Oct 29, 2008 09:13 AM J.P. Morgan Downgrades Johnson & Johnson (JNJ) to Neutral

Oct 23, 2008 09:47 AM Deutsche Bank Downgrades Zimmer Holdings (ZMH) to Hold

Feb 13, 2007 10:15 AM S&P Equity Research Downgrades Johnson & Johnson (JNJ) to Buy

Oct 16, 2006 02:22 PM S&P Equity Research Downgrades Liz Claiborne (LIZ) to Hold

Oct 5, 2006 09:40 AM Hilliard Lyons Downgrades Johnson & Johnson (JNJ) to Long-term Buy

Jun 26, 2006 10:25 AM KeyBanc downgrades Johnson & Johnson (JNJ) to Hold